MHQP to Play Key Role in CMS-Funded Orthopedics Measurement Development Project
MHQP is pleased to announce that we will be partnering with principal investigators from Brigham and Women’s Hospital in a cooperative agreement funded through the Centers for Medicare & Medicaid Services (CMS) and authorized under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) to develop clinical quality measures related to orthopedic surgery.
MHQP’s role in the three-year project, entitled Measuring Outcomes in Orthopedics Routinely (MOOR), will be to engage stakeholders in the measure development process through focus groups, semi-structured interviews, and multi-stakeholder co-design workshops.
The U.S. is the process of transitioning from a fee-for-service system to a pay-for-performance approach for billing Medicare and Medicaid services. In the new system, effective and reliable measures will be needed to assess the quality of services rendered. This project is one of seven grants awarded by CMS to create these measures.
“MHQP is excited to engage with the world-class professionals at the Brigham in this important project,” said MHQP’s President and CEO Barbra Rabson. “The challenges facing healthcare can only be solved through collaboration and innovation across key stakeholder groups – providers, health plans and patients – and we look forward to bringing their voices to the development of these measures.”
“MHQP’s unique position as an independent coalition of stakeholder groups in Massachusetts healthcare makes them the ideal partner for this project,” said principal investigator David Bates, MD, MS. “We are grateful that they are able to make this important contribution to the success of this work.”
The project will begin this fall.